Vyome Holdings (HIND) Other Operating Expenses (2020 - 2026)
Vyome Holdings (HIND) posted Other Operating Expenses of $2610.0 for Q2 2026, little changed on a QoQ basis from $2605.0 in Q1 2026, and up 100.37% year-over-year from $1302.6 in Q2 2025.
Analysis
Vyome Holdings (HIND) Other Operating Expenses (2020 - 2026) Analysis & Trends
Vyome Holdings has reported Other Operating Expenses for 7 years, with the latest figure at $2610.0 in Q2 2026.
- On a quarterly basis, Other Operating Expenses rose 100.37% year-over-year to $2610.0 in Q2 2026; TTM through Jun 2026 was $7.7 million, a 803.9% increase from a year earlier, with the FY2025 full-year figure at $7.7 million, up 866.65% from the prior year.
- Other Operating Expenses was $2610.0 for Q2 2026 at Vyome Holdings, roughly flat from $2605.0 in the prior quarter.
- The five-year high for Other Operating Expenses was $7.7 million in Q3 2025, with the low at -$708032.0 in Q2 2025.
- Average Other Operating Expenses over 5 years is $817626.5, with a median of $3276.0 recorded in 2024.
- The largest YoY upside for Other Operating Expenses was 174021.05% in 2025 against a maximum downside of 277.45% in 2025.
- Over 5 years, Other Operating Expenses stood at -$146000.0 in 2022, then soared by 122.6% to $33000.0 in 2023, then plunged by 88.29% to $3864.0 in 2024, then tumbled by 30.43% to $2688.0 in 2025, then dropped by 2.9% to $2610.0 in 2026.
- The last three Other Operating Expenses figures came in at $2610.0 (Q2 2026), $2605.0 (Q1 2026), and $2688.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Vyome Holdings | 14.46 Mn | 6.57 Mn | 11,658.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2,610.00 |
| Mar 31, 2026 | 2,605.00 |
| Dec 31, 2025 | 2,688.00 |
| Sep 30, 2025 | 7.71 Mn |
| Jun 30, 2025 | -708,032.00 |
| Mar 31, 2025 | -396,477.00 |
| Dec 31, 2024 | 3,864.00 |
| Sep 30, 2024 | 4,427.00 |
| Jun 30, 2024 | 399,000.00 |
| Mar 31, 2024 | 484,000.00 |
| Jun 30, 2023 | 33,000.00 |
| Mar 31, 2023 | 2.18 Mn |
| Dec 31, 2022 | -146,000.00 |
| Sep 30, 2022 | -1,000.00 |
| Jun 30, 2022 | -381,000.00 |
| Mar 31, 2022 | 3.89 Mn |
| Dec 31, 2021 | 33.61 Mn |
| Sep 30, 2021 | 3.25 Mn |
| Jun 30, 2021 | 1.44 Mn |
| Mar 31, 2021 | 1.25 Mn |